Purpose Tobacco and alcohol use are well-known risk factors for squamous cell carcinoma of the head and neck (SCCHN), but there has been little examination of disparities in SCCHN and racial patterns of tobacco and alcohol use, especially for African-Americans. The Carolina Head and Neck Cancer Study, a population-based case-control study, was utilized to determine whether relationships between tobacco and alcohol use and SCCHN differed by race. Methods Using a rapid case ascertainment system, cases were recruited from 46 contiguous counties in North Carolina from 2002 to 2006. Controls, selected from motor vehicle records, were frequency-matched to cases on age, sex, and race. This analysis was based on 989 white and 351 African-American cases and 1,114 white and 264 African-American controls. Analyses were performed using unconditional logistic regression, adjusting for age, sex, race, education, and fruit and vegetable consumption. Results The association between SCCHN and ever tobacco use among African-Americans (odds ratio (OR), 9.68; 95 % confidence interval (CI), 4.70, 19.9) was much greater than that observed in whites (OR, 1.94; 95 % CI, 1.51, 2.50). Smaller differences were observed when examining ever alcohol use (African-Americans: OR, 3.71; CI, 1.65, 8.30, and Whites: OR, 1.31: CI 0.96, 1.78). African-Americans consistently had greater effect measure estimates when examining common levels of duration and intensity metrics of tobacco and alcohol use, both independently and jointly. No racial differences in the effects of environmental (passive) tobacco smoke were observed. Conclusions These findings suggest racial differences in SCCHN are not solely explained by differences in consumption patterns, and tobacco and alcohol may have greater impact in African-Americans.
Introduction
Squamous cell carcinoma of the head and neck (SCCHN) is one of the ten most frequently diagnosed cancers globally and consists of cancers found in the oral cavity, pharynx, and larynx [1] . Within the United States, the American Cancer Society estimates that there will be 52,140 new cases and 11,460 deaths attributable to these cancers in 2011 [2] . Data from the National Cancer Institute's Surveillance Epidemiology and End Results database (SEER) suggest racial disparities in incidence and mortality related to these cancers, with African-American males bearing the largest burden of disease [3] . These disparities are especially pronounced for laryngeal cancer. From 1975 to 2008, the age-adjusted incidence rate for laryngeal cancer among African-American males was 12.8 per 100,000, compared to 8.0 in White males, 2.5 in Black females, and 1.6 in White females [4] . African-American males also have the greatest rate of oropharyngeal cancer, 21.8 per 100,000 compared to 17.9 for White males, 7.1 for White females and 7.0 for AfricanAmerican females, although in recent years the rate among White males has been increasing [4] . In North Carolina, the 2005--2009 age-adjusted incidence rate for SCCHN was 10.2 per 100,000 among whites and 12.4 per 100,000 among African-Americans. There is also a disparity in mortality in North Carolina with an age-adjusted mortality rate per 100,000 people of 3.0 among whites and 5.6 among AfricanAmericans [5] .
Tobacco use and alcohol consumption have been consistently demonstrated to be risk factors for SCCHN in U.S. and international epidemiologic studies [6] . Findings document clear dose-response relationships and evidence of interaction between tobacco and alcohol use in contributing to SCCHN risk [7, 8] . Previous research estimated that use of tobacco and/or alcohol may account for three-fourths of all oral and pharyngeal cancers in the United States [7] . Since then, research suggests that infection with human papillomavirus (HPV) may also contribute to certain subtypes of SCCHN, particularly among non-smokers and non-drinkers [9, 10] .
Despite the evidence that SCCHN incidence varies by race and, overall, may be largely attributable to tobacco and alcohol use, there has been little focus on differences in consumption patterns between ethnic and racial groups, especially for African-Americans. Using data from a casecontrol study conducted between 1984 and 1985, Day et al. [11] conducted one of the few comparisons of risk factors between African-Americans and whites and found slightly different consumption patterns by race. Their findings, based on 194 African-American cases, showed similar odds of oral and pharyngeal cancer associated with tobacco use between the groups but noted some differences in the relationship between alcohol consumption and oral cancer, with AfricanAmericans having greater odds of disease. Laryngeal cancer was not included in their case-study group.
The objective of the present analysis was to utilize a large population-based case-control study of oral, pharyngeal and laryngeal cancers, in order to determine whether the relationships between tobacco and alcohol use and risk of SCCHN were different for African-Americans and whites. This analysis included examination of the interaction between tobacco and alcohol use and stratification by different sites of SCCHN.
Materials and methods
The Carolina Head and Neck Cancer Study (CHANCE) included cases, aged 20-80, who were residents of a 46-county region in North Carolina with newly diagnosed first primary invasive SCCHN between January 1, 2002 and February 28, 2006 [12] . We included ICD-O-3 topography codes C01.9-C14.8 and C32.0-C32. 9 . We excluded tumors of the lip (C0.00-C00.9), salivary glands (C07.9, C08.0-C08.9), nasopharynx (C11.0-C11.9), nasal cavity (C30.0), and nasal sinuses (C31.0-C31.9). Subjects with carcinomas of other histologies, carcinomas at other head and neck sites, or a history of recurrent or second primary tumors were not eligible. Using rapid case ascertainment conducted through the North Carolina Central Cancer Registry, cancer registrars at the 54 hospitals in the study were contacted monthly to identify and provide eligible, newly diagnosed cases. Pathology reports and corresponding slides of tumor specimens from the patient's diagnostic surgery were obtained, usually within 4-8 weeks of diagnosis, and histologic confirmation was verified by our study pathologist (WF).
Controls, aged 20-80 years, were residents of the same 46 North Carolina counties and had never been diagnosed with SCCHN. Identified through North Carolina Department of Motor Vehicle records, controls were frequency matched with cases using random sampling with stratification on age (20-49,50-54,55-59,60-64,65-69,70-74,75-80), race (white, black, other), and sex (male and female).
Potentially eligible controls and cases (after physician notification) were first contacted by mail and then by nurseinterviewers to verify eligibility and schedule an interview. Written informed consent was obtained prior to the interview, and participants received compensation for time spent completing the study interview and donating a biologic sample. For subjects who were deceased, an attempt was made to locate a family member or proxy with knowledge of the subject's exposures who was willing to complete an abridged version of the survey. All study protocols were reviewed and approved by the University of North Carolina's Institutional Review Board.
Demographics and exposure to potential SCCHN risk factors and covariates were assessed during the in-person interview using standardized survey questions. Each potential risk factor was assessed in a separate section including a gateway question with ever-use defined as: smoking 100 cigarettes over a lifetime; smoking 20 cigars; use of a pipe at least 20 times; use of chewing tobacco at least 20 times; use of snuff at least 20 times; drinking 50 beers over a lifetime; drinking wine 20 times; and drinking hard liquor 20 times. A positive response to the gateway question triggered additional questions on age started, age stopped use if quit, years of use, type of cigarette or size of typical alcoholic drink and typical amount used/consumed. Cases were asked about use the year prior to diagnosis while controls were asked about current use. Environmental (second hand, passive, involuntary) tobacco smoke (ETS) exposure was determined by asking if participants had been exposed to tobacco smoke at work or home and the number of cigarettes, cigars, or pipefulls that each person in the household smoked inside the home.
Using responses to these questions and based on the distribution, cigarette and alcohol use were classified by intensity, duration, and cumulative use. The number of cigarettes smoked per day was categorized into the following: never-smoker, less than 19 cigarettes per day, and 20 or more cigarettes per day. Duration was defined in years using the categories of never-smoker, 1-19, 20-39, 40-49 and 50 or more. Cumulative use was defined by pack-years, calculated by multiplying the number of cigarette packs (20 cigarettes per pack) smoked per day by the total number of years smoked and then categorized into never-smokers, less than 20 pack-years, and 20 or more.
Beer, liquor, and wine consumption were each coded as six-level variables with the following categories: 0, \1, 1-4, 5-14, 15-29, and 30 or more drinks per week. Duration of consumption of each of these beverages was coded as: never, 1-9, 10-19 years, and 20 or more years. Cumulative alcohol use was calculated by converting the number of each type of drink consumed per week to total ethanol grams then multiplying by years that type of alcohol was consumed and then summing across the three types of alcohol. Subsequently, the cumulative, or total, alcohol variable was categorized into a 5-level variable, with a never drinker category and four categories defined by quartiles of consumption among all participants to prevent the undue influence of extreme values.
The odds ratio (OR) estimate for the effect of each exposure on SCCHN was obtained using unconditional logistic regression, with the matching factors and their interactions included within each model. Based on review of the literature, all models were a priori adjusted for education, classified as high school or less, some college, and college degree or more, and quintiles of fruit and vegetable consumption [13] . Fruit and vegetable consumption were separately calculated based on reported dietary intake [13] . Proxy respondents were excluded from multivariable analysis because they lacked data on fruit and vegetable consumption. Models with cigarette exposure variables as the main exposure also adjusted for alcohol consumption, using the categorical variable of total ethanol consumed, and use of other tobacco products. Models examining other tobacco use variables adjusted for alcohol consumption and duration of cigarette smoking. Models focusing on alcohol use variables also adjusted for duration of cigarette smoking and use of other tobacco products.
To examine differences in risk factors for SCCHN between African-Americans and whites, we included an interaction term between the exposure and race and conducted likelihood ratio tests, specifying an alpha level of 0.10. Models were also stratified by cancer site, using the following definitions: oral cavity (ICD-O-3 C01.9-C02.3, C03.0-C03.1, C03.9, C04.0-C04.4, C04.8-C05.0, C06.0-C06.2, C06.8-C06.9), oropharynx (C02.4, C05.1-C05.2, C09.0-C09.1, C09.8-C10.4, C10.8-C10.9), hypopharynx (C12.9-C13.2, C13.8-C13.9), oral cavity-oropharynxhypopharynx not otherwise specified (C02.8-C02.9, C05.8-C05.9, C014.0), or larynx (C32.0-C32.9). Additional analyses were stratified by cancer sites that are known to be related to HPV infection (C01.9-base of tongue, NOS, C02.4-lingual tonsil, C09.0-C09.9-tonsil, C10.0-C10.9-oropharynx) [10] , as it is hypothesized that tobacco and alcohol would play less of a role in the etiology of these cancers. When examining the data by site, some exposure categories were collapsed due to smaller sample size.
In order to examine joint effects of tobacco and alcohol exposure, we constructed an unconditional logistic regression model that included interaction terms between duration of cigarette smoking and weekly alcohol consumption, defined as total number of drinks per week. We chose these two measures of tobacco and alcohol consumption in order to explore the combination of the most definitive metrics representing the highest risk behaviors identified in earlier analyses. Due to small sample size, we combined the never drinkers and very light drinkers (\1 drink per week) into a single category. To explore interaction on the additive scale, interaction contrast ratios (ICRs) and 95 % confidence intervals were calculated comparing those who used the greatest amounts of both tobacco and alcohol to those with no tobacco and alcohol use [14] . All analyses were performed using SASv9.2.
Results
Case response proportions were similar between AfricanAmericans and whites, 74.9 and 77.0 %. Control response Table 2 , the odds ratios for measures of cigarette smoking intensity and duration are larger in magnitude for AfricanAmericans than whites, although the estimates for AfricanAmericans are less precise. Among those at the higher levels of duration and cigarettes per day of cigarette use, AfricanAmericans had a six-ninefold greater odds of SCCHN than among whites. Likelihood ratio tests indicated that these differences are statistically significant and suggest that race modifies the relationship between various measures of cigarette use and the effect on SCCHN incidence. We examined finer categorizations of cigarettes per day and found the racial differences in odds of cancer remained. Among African-Americans, odds ratios for 1-19, 20- 
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Cases n = 351 Controls n = 264 Cases n = 989 Controls n = 1,114 category. We also examined pack-years smoked and found similar results, with African-Americans consistently having higher odds ratios than whites (data not shown).
SCCHN risk decreased as the number of years since quitting increased for both races, but the odds ratios remained greater, but more imprecise, among AfricanAmericans. There was also a stronger relationship between initiating cigarette use at a younger age and SCCHN among African-Americans than whites. When examining type of cigarette smoked, there was a greater variability in odds of disease among African-Americans. However, these estimates were imprecise. When we examined the individual effects of other types of tobacco, simultaneously controlling for the others as well as cigarette use, we did not observe any strong relationships with the odds of SCCHN (Table 2) . After stratifying by race, we observed elevated, though imprecise, ORs among African-Americans when examining the relationship between use of either snuff or chew and SCCHN, and the likelihood ratio test examining the interaction between race and snuff use was statistically significant using our criteria of 0.10. In order to differentiate the effects of other types of tobacco from each other as well as from cigarette use, we created a variable, which separates use of a single form of tobacco from using multiple types. As seen in Table 2 , those who smoked cigars and/or pipes only also have elevated odds of SCCHN. The odds of SCCHN associated with the use of multiple types of smokeable tobacco was not greater than using cigarettes alone. The small number of cases who used smokeless tobacco alone made interpretation difficult due to poor precision, but African-Americans who used only smokeless tobacco had a slightly elevated odds of SCCHN.
In order to detangle the effects of active tobacco use from ETS, we stratified the ETS models by ever-use of tobacco products (Table 3) . Among never users of tobacco, odds ratio estimates for different measures of ETS exposure were less than 1. Among self-tobacco users, exposure to ETS was associated with SCCHN, and the odds ratios trended higher as the amount of ETS exposure increased. This relationship is seen in both African-Americans and whites.
For alcohol consumption, there were racial differences in the magnitude of associations with SCCHN, although these differences were smaller than those observed for cigarette use. The odds ratio corresponding to any lifetime alcohol use among African-Americans (OR, 3.71; 95 % CI, 1.65, 8.30) was almost triple that observed among whites (OR, 1.31; 95 % CI, 0.96 and 1.78). Both races showed greater odds of disease as either amount or duration of alcohol consumption increased, with African-Americans consistently having slightly larger odds ratio estimates (Table 4) . Using the total alcohol variable, among both racial groups, we observed that the lowest levels of consumption were associated with decreased odds of SCCHN, while the highest levels of consumption were associated with greater odds of SCCHN. Odds ratios related to wine consumption were lower than beer or liquor consumption, particularly among whites, where ever wine consumption was associated with reduced odds of SCCHN compared to non-drinkers and only the highest level of wine consumption (more than 30 drinks per week) was associated with greater odds of SCCHN.
Compared to non-drinkers/very light drinkers and nonsmokers, the joint effect of alcohol and tobacco increased as amount increased, especially for African-Americans ( Table 5 ). Some of these estimates were very imprecise due to the small numbers within cells. For the assessment of the additive interaction of consuming the greatest amounts of alcohol and tobacco compared to non-users, the overall ICR was 10.3 (95 % CI 3.81, 16.8), suggesting excess risk due to the interaction between tobacco and alcohol. When stratifying by race, the ICR for whites was 5.98 (95 % CI, -0.08, 12.0) and 138 (95 % CI, -141, 418) for African-Americans. Among Whites, the odds ratio comparing the highest alcohol users to non/very light drinkers among non-smokers is similar to the odds ratio comparing the highest users of tobacco to non-smokers among non/very light drinkers (Table 5 ). Among AfricanAmericans, however, the odds ratios suggest that alcohol consumption has less of an effect on non-smokers than smoking has among non/very light drinkers.
Stratifying by site of primary tumor showed that the relationship between tobacco use and cancer was consistently greatest for laryngeal tumors, and wine consumption was associated with reduced odds of SCCHN among oral cavity and laryngeal cases (Online Resource 1, Supplementary Table 1 ). African-Americans and whites had similar tumor site distributions, although hypopharynx tumors made up approximately 8 % of African-American cases, compared to only 4 % among white cases. When stratifying by both race and site, African-Americans continued to have greater effect measure estimates related to smoking and alcohol use than whites for all tumor sites except hypopharynx tumors. However, these stratified results are based on very small numbers and are highly imprecise. (Online Resource 1, Supplementary Tables 2  and 3 ) Whites were slightly more likely to have a tumor site with presumed HPV-infection than African-Americans (26.5 vs. 21.6 %). The association between tobacco use and SCCHN was consistently greater among those whose tumor site was not associated with presumed HPV-infection (Online Resource 1, Supplementary Table 4 ). The same was true for beer consumption, but not for wine and liquor consumption. When examining these results stratified by race, African-Americans with HPV-related tumor sites have greater odds of SCCHN corresponding to tobacco and alcohol use compared to those with non-HPVrelated sites, although these estimates were highly CI confidence interval, df degrees of freedom, OR odds ratio All models exclude missing data. Crude models adjusted for matching factors and their interactions. Adjusted models include matching factors, their interactions, and education, fruit and vegetable consumption and total alcohol consumption Likelihood ratio test for effect measure modification by race: any exposure in the home: X 2 = 0.003, df = 1, p = 0.96; amount of cigarettes exposed to daily: X 2 = 2.64, df = 3, p = 0.45
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We ran additional models that adjusted for each type of alcohol separately, as opposed to the total consumption variable, as well as models that adjusted for tobacco using pack-years and found no material difference in the estimates obtained (data not shown). We also ran joint models using pack-years instead of year of smoking and found similar results (data not shown). To determine whether the racial disparities observed were due to residual CI confidence interval, df degrees of freedom, OR odds ratio All models exclude missing data. Crude models adjusted for matching factors and their interactions. Adjusted models include matching factors, their interactions, and education, fruit and vegetable consumption, duration of cigarette smoking, ever use of other tobacco products and use of other alcohol types confounding related to education, we reran our analyses using a finer adjustment variable that included 7 levels of education (\8, 8-11 years, completed high school, vocational work, some college, college graduate and postgraduate). This finer educational adjustment did not have a material effect on our results and the racial disparities in the effects of tobacco and alcohol use remained. No difference in results were found when using conditional logistic regression models to account for matching. Appropriate model fit was explored and verified by examining model residuals and delta-betas.
Discussion
This study found the effects of tobacco use and alcohol consumption on odds of SCCHN were consistently greater among African-Americans, whether measuring exposure by intensity, duration, or cumulative use. Additionally, the joint effect of tobacco and alcohol use, as well as the impact of smoking among non-drinkers and the impact of greater smoking frequency and duration among smokers was greater among African-Americans. These findings suggest that previously observed racial differences in SCCHN incidence are not solely explained by differences in consumption patterns between African-Americans and whites, and the impact of tobacco and alcohol may be stronger in African-Americans. Our estimates of SCCHN related to tobacco and alcohol use among whites are consistent with reports from the International Head and Neck Cancer Epidemiology Consortium (INHANCE), a pooled analysis of 15 case-control studies [8, [15] [16] [17] . For example, their odds ratio comparing those who consumed more than 30 drinks of beer per week to non-drinkers of 3.2 (2.2, 4.7) was just slightly higher than our result of 2.85 (1.96, 4.16) [15] . Both studies found the relationship between tobacco and SCCHN strongest among laryngeal cases, with increasing odds of cancer as metrics of smoking duration increased [17] . Our findings of strong interaction between tobacco and alcohol in contributing to the odds of SCCHN and a lack of an association when examining ever ETS exposure among never tobacco users are also consistent with INHANCE analyses [8, 16] . The reduced risk of SCCHN with wine consumption, among whites observed in our study, was not seen in the INHANCE analysis but has been observed in other case-control studies of SCCHN [11] .
Our results were not entirely consistent with the previous study of differences between whites and blacks in risk factors for oropharyngeal carcinoma [11] . Although we found similar racial differences in the relationship between alcohol use and SCCHN, Day et al. did not find any difference in the race-stratified odds ratios corresponding to any cigarette use. Day et al. [11] did not include laryngeal cases in their analysis, and our results showed that the relationship between tobacco use and SCCHN was strongest in laryngeal cases. However, we continued to observe racial differences in odds ratios when we restricted to only oral or oropharyngeal tumor sites, although the estimates were imprecise due to small numbers. It is possible that, because the previous study was conducted in the mid1980s, changing tobacco consumption patterns may explain the differences in our results.
It has been suggested that racial disparities in tobaccorelated cancers may be due to the greater use of mentholated cigarettes among African-Americans [18] . Previous research in both oropharyngeal and lung cancers have found no excess cancer risk among smokers of mentholated cigarettes compared to non-mentholated cigarette smokers [18] [19] [20] . In our study, we found that smokers of both unfiltered and filtered menthol cigarettes had the greatest odds of cancer, although these effect estimates were imprecise. When we focused on those who smoke filtered cigarettes only, our results among whites show there is little difference in the odds of SCCHN when comparing those who smoked menthol cigarettes with those who smoked non-menthol cigarettes. Among African-Americans, smokers of filtered menthol cigarettes have lower odds than those who smoked filtered non-menthol cigarettes, similar to a recent study of lung cancer by Blot et al. [20] , which also observed lower odds of cancer among menthol cigarette smokers, among both African-Americans and whites. It is unclear whether mentholation itself or smoking behaviors and other characteristics of smokers who choose mentholated cigarettes contribute to these findings.
Day et al. did not examine other forms of tobacco use, but we observed racial differences in the relationship between smokeless tobacco and SCCHN. A review by Boffetta et al. [21] examined 11 studies in the US and Europe and found an increased risk of oral cancer associated with smokeless tobacco among US-based studies (summary relative risk (RR); 95 % CI 2.6 (1.3, 5.2)) but not among those conducted in Europe (summary RR; 95 % CI 1.0 (0.7, 1.3)). Among the US studies, there was evidence of heterogeneity, with two studies observing null results and larger effect estimates observed in studies of women only. We did not find strong associations between smokeless tobacco and SCCHN overall, but we did observe a greater association for snuff use when we restricted to only oral cavity sites (OR; 95 % CI, 0.99 (0.61, 1.60) to 1.31 (0.48, 3.61), all sites vs. oral cavity only). Only one of the previous studies stratified by race and found greater odds of disease among white women who reported using dry snuff [22] . It was noted that the snuff used by these women had very high nitrosamine concentrations. It is possible that racial differences in the type of snuff used, as well as usage patterns, may contribute to the differences observed in our study.
Our findings that African-Americans had a greater odds of SCCHN associated with total alcohol consumption were consistent with the previous study of racial disparities in oropharyngeal cancer, but we obtained slightly different results when examining the effects of consumption frequency for the different types of alcohol. In Day et al., whites had greater odds ratios related to frequency of beer consumption than African-Americans, while AfricanAmericans had greater odds ratios related to wine and hard liquor consumption. In our study, African-Americans had greater effects across all three types of alcohol. In general, the odds ratios related to alcohol consumption for AfricanAmericans tended to be higher in our study. The odds ratios among whites tended to be higher in the previous study, especially at the higher levels of consumption. For example, in our study, whites who consumed 30 or more servings of beer per week had an odds ratio of 2.5 (95 % CI, 1.64, 3.81) while Day et al. [11] observed an odds ratio of 6.2 (95 % CI, 3.9, 9.9). These differences could be partly due to the use of a different referent group in the two studies (combination of light and non-drinkers vs nondrinkers in the Day's study) or the inclusion of laryngeal cases in our study. Additionally, changes in the ethanol content of the average beer consumed over the last two decades could also contribute to the differences observed in our study. For example, light beers, with lower ethanol contents, have increased their market share steadily since the late 1980s [23] . Because neither study incorporated type of beer or specific alcohol contents into the analysis, it is possible that a 12oz serving of beer, the metric of beer consumption used, represents slightly different ethanol amounts, causing differences in the observed odds of SCCHN.
Although we explored finer adjustments of education in our analysis, residual confounding related to unmeasured socioeconomic factors is one potential explanation for our findings, as previous research suggests associations between cancer incidence and socioeconomic status can vary by race [24, 25] . Recent research suggests that African-Americans and Whites may smoke cigarettes differently, with African-Americans smoking lower numbers of cigarettes per day more intensely, leading to higher values of biomarkers of exposure to nicotine and potential differences in carcinogen exposure given the same reported consumption of cigarettes [26] .
Similarly, previous research has shown that AfricanAmericans and whites consume different types of alcohol, which could explain some of the differences observed in their odds of SCCHN. Rothman et al. [27] reported that the risk of hypopharyngeal cancer was higher in those who consumed dark liquors when compared to light liquors, while the risk of laryngeal cancer was relatively similar. Dark liquors, like cognacs, whiskeys, and dark rums, contain higher levels of non-alcoholic chemicals that could be potential carcinogens [27] . While Day et al. [11] observed that African-Americans were more likely to drink dark liquor, they did not see any difference in the odds of SCCHN related to different types of liquor. There has been research which observed differences in cancer risk when examining consumption of red versus white wine [28, 29] , although other studies have observed no difference [30] . It is plausible that differences in the specific types of alcoholic beverages consumed could contribute to the differences observed in our study.
It is also possible that racial differences in tobacco and alcohol metabolism could explain our results. Previous work among healthy smokers found that African-Americans had a lower ratio of urinary detoxification by-products to metabolites of the tobacco-related carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), compared to whites. This ratio is thought to be a measure of tobacco detoxification capacity [31] . Additionally, a number of studies, with mixed results, have examined the relationship between SCCHN and polymorphisms in genes that code for the metabolic enzymes which are involved in either the activation or detoxification of chemicals found in tobacco and/or alcohol, although there has been limited research in African-American populations [32, 33] . A meta-analysis by Varela-Lema et al. [34] found an association between one of these polymorphisms, GSTM1-deletion, and oral cancer only among African-Americans and other populations of African descent, suggesting the potential for gene-gene or gene-environment interactions to explain racial disparities in cancer incidence.
Previous research suggests that although men are more likely to have SCCHN, than women, the relationship between tobacco and SCCHN is stronger in women [35] . It is possible that gender differences between the racial groups being compared could cause differences in the observed odds ratios. However, there were similar percentages of women in both the African-American and White groups, and we matched on and adjusted for sex in our study. Additionally, we conducted a sex-and racestratified analysis and found that racial differences persisted although effect measure estimates were higher, but highly imprecise due to small numbers of women, consistent with previous research. For example, odds ratios for smoking more than 20 cigarettes per day were 2.05 (1.49, 2.82) and 4.63 (3.00, 7.15) in white and African-American men, respectively, but 10.7 (4.99, 22.7) and 24.0 (10.6, 54.6) in white and African-American women, respectively.
Our study is among the largest individual populationbased studies of head and neck cancer conducted in the United States. We were able to collect and examine detailed information about intensity and duration of tobacco and alcohol use in both African-Americans and whites, enabling us to determine how the independent and joint effects of these factors may differentially impact racial groups. We had a large enough sample size to examine the relationship between tobacco and alcohol with different tumor sites, and the population-based design gives us confidence that our results are generalizable to the underlying population.
Although we have a larger number of African-Americans in our sample than previous studies, the still relatively small number led to imprecise estimates when examining certain exposures. We did not have molecular confirmation of HPV-related cases. Our classification relied on previous research, which identified sites shown to be associated with HPV infection [10] . Despite this potential for misclassification, our tobacco-related findings among whites were relatively consistent with previous studies, which utilized serology to identify HPV-related cases, although we did not observe differences in SCCHN and alcohol use associations by HPV-status similar to previous studies [36, 37] . Our response among controls was low at 48 % and varied by race with African-American controls having a lower response. While we do not have data on persons who refused participation, our overall findings regarding tobacco and alcohol as risk factors for SCCHN are consistent with the literature, supporting the validity of our study. Comparing our controls to results from the 2002-2005 Behavioral Risk Factor Surveillance System (BRFSS) surveys in North Carolina suggests that the controls were more likely to ever smoke than the general adult population of North Carolina within the relevant age range, although our controls were more likely to be male which could explain part of this discrepancy [38] . This control selection could have caused our estimates to be lower in magnitude, but would not likely explain the large differences observed between African-Americans and Whites as both races had greater prevalence of smoking than their BRFSS counterparts. While recall bias is a limitation inherent to the case-control design, there is no evidence to suggest that recall of tobacco and alcohol use varies by race.
In summary, our study found that the relationships between tobacco, alcohol, and SCCHN vary by race, with these risk factors having a greater impact on AfricanAmericans. These differences may be explained by differences in metabolism, use and cessation patterns and/or socioeconomic factors that are not fully accounted in our study. Future studies should continue to examine racial differences in patterns and metabolism of tobacco and alcohol in order to understand the racial disparities in SCCHN observed in the United States.
